查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1401805

基因治療市場，按載體類型、按基因類型、按治療、按應用、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Gene Therapy Market, By Vector Type, By Gene Type, By Therapy, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年基因治療市場規模達 83 億美元，2023 年至 2030 年複合CAGR為 22.3%。

基因治療市場-市場動態

全球癌症、罕見疾病遺傳性疾病等慢性疾病盛行率的增加預計將推動基因治療市場的成長。

基因療法透過專門針對導致癌症進展的潛在遺傳異常，提供了一種有前景的抗癌策略。根據世界衛生組織的數據，2020 年全球約有 1,810 萬癌症病例，其中男性 930 萬，女性 880 萬人。雖然基因療法主要著重於解決缺乏有效傳統治療方案的罕見遺傳性疾病，但國家生物技術資訊中心估計，每年有495,000 名嬰兒出生時患有先天性畸形，其中39 萬名嬰兒患有G6PD 缺乏症，21,400名嬰兒患有唐氏症，9,000 名嬰兒患有BETA--地中海貧血、5,200 名鐮狀細胞疾病患者和 9,760 名氨基酸失調患者。透過根據個人的特定基因譜量身定做治療，基因治療可以實現更個人化的醫療保健方法。此外，增加基因治療研究和開發的投資和資助可以為市場成長創造機會。然而，與基因療法相關的巨額成本在報銷和可及性方面提出了挑戰。

基因治療市場-關鍵見解

根據我們的研究分析師分享的分析，預計全球基因治療市場在預測期內（2023-2030）每年將以 22.3% 左右的CAGR成長

根據載體類型細分，預計非病毒載體將在 2022 年顯示最大的市場佔有率

根據基因類型細分，抗原類型是2022年的主導類型

從治療細分來看，2022年體內治療為主導類型

根據應用細分，腫瘤疾病是 2022 年的主導類型

按地區分類，北美是 2022 年的主要收入來源

基因治療市場-細分分析：

全球基因治療市場根據載體類型、基因類型、治療、應用和區域進行細分。

根據載體類型將市場分為三類：病毒載體和非病毒載體。該市場主要由非病毒載體主導。一般來說，與病毒載體相比，非病毒載體表現出優越的安全性，從而最大限度地減少免疫反應或意外副作用的機會。此外，非病毒載體能夠容納更大的DNA有效負載，從而能夠遞送更廣泛的遺傳物質。

市場依基因類型分為兩類：抗原、細胞激素、腫瘤抑制因子、自殺因子、缺乏因子、生長因子、受體和其他。抗原部分主導市場。基因治療在增強免疫系統識別和攻擊與疾病相關的特定抗原的能力方面發揮著重要作用。

根據治療，市場分為三類：體內治療和體外治療。體內療法在市場上佔據主導地位。體內療法在市場上佔有重要地位。研究人員正在積極研究各種疾病的體內基因療法，例如遺傳性疾病、特定形式的癌症和其他醫療狀況。目的是修改患者的遺傳物質以提供治療優勢。

市場依應用分為三類：腫瘤疾病、罕見疾病、神經疾病和其他疾病。該市場主要由腫瘤疾病領域主導。幾種針對腫瘤疾病的基因療法目前正在進行不同階段的臨床試驗。某些療法已獲得特定適應症的監管批准，而其他療法仍處於研究階段。

基因治療市場-地理洞察

從地理來看，這個市場遍及北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些區域根據業務涉及的國家進一步分類。由於其高度先進的醫院基礎設施以及對細胞和基因治療不斷成長的需求，預計北美地區將主導市場的成長。北美擁有強大的醫療保健生態系統，其特點是學術界、工業界和醫療保健提供者之間的合作。這種協作環境促進創新並加速將科學發現轉化為臨床應用。根據美國醫院資訊科技協會的數據，2018 年，98.3% 的醫院採用了電子健康記錄 (EHR)，並且根據關鍵訪問醫院 (CAH) 狀態沒有差異。此外，58.7% 和 55.6% 的醫院分別採用了先進的病患參與 (PE) 和臨床文件架構 (CDA) 功能。人們越來越認知到細胞和基因療法在治療各種疾病（包括癌症和遺傳性疾病）方面的潛力，導致對這些療法的需求增加。截至2022 年12 月，美國食品藥物管理局(FDA) 已批准四種基因療法在美國(US) 銷售：2017 年批准的Luxterna (voretigene neparvovec)、2019 年批准的Zolgensma (onasemnogene abeparvovec-xioi)、 Tecartus (brexucabtagene autoleucel) 於 2020 年獲得批准，Hemgenix (etranacogen dezaparvovec) 於 2022 年獲得批准。雖然仍處於早期階段，但基因療法具有治療和治愈以前被認為無法治療的疾病的潛力。預計歐洲將在未來幾年成為第二大基因治療市場，這主要是由於對個人化基因治療的需求不斷成長。

基因治療市場-競爭格局：

基因治療市場正在經歷顯著成長，針對各種適應症正在開發多種療法。這呈現出一個競爭格局，需要徹底的分析，以確定基因治療開發商的機會和挑戰。在製藥業，細胞和基因療法的出現帶來了創新的治療方法，公司專注於專利並進行策略性投資以引進先進技術。這些投資不僅增強了專利組合，而且使關鍵參與者處於行業進步的最前沿。最近的交易凸顯了細胞和基因療法在製藥領域的重要性，戰略合作夥伴關係、專利和就業趨勢發生了動態變化。美國在全球採用方面處於領先地位，其協作努力、變革性專利和不斷變化的就業機會塑造了創新進步的未來。隨著越來越多的基因療法進入市場，公司必須有效地準備其產品和上市策略，以履行其改變患者生活的承諾。這些公司必須以最大限度提高患者利益的方式推出產品，同時確保在市場上取得成功。

最近的發展：

2021年12月22日，諾華宣布簽訂最終協議，收購英國眼部基因治療公司Gyrscope Therapeutics的全部已發行股本。地圖狀萎縮是乾性老年黃斑部病變的一種高級形式，會導致高級且不可逆的思維喪失1。

目錄

第1章：基因治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按載體類型分類的基因治療市場片段
    • 按基因類型分類的基因治療市場片段
    • 基因治療市場片段（按療法）
    • 基因治療市場片段（按應用）
    • 按國家/地區分類的基因治療市場片段
    • 按地區分類的基因治療市場片段
  • 競爭洞察

第 3 章：基因治療主要市場趨勢

  • 基因治療市場促進因素
    • 市場促進因素的影響分析
  • 基因治療市場限制
    • 市場限制影響分析
  • 基因治療市場機會
  • 基因治療市場未來趨勢

第 4 章：基因治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：基因治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：基因治療市場格局

  • 2022 年基因治療市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：基因治療市場 - 按載體類型

  • 概述
    • 按向量類型分類的細分市場佔有率分析
    • 病毒載體
    • 非病毒載體

第 8 章：基因治療市場 - 按基因類型

  • 概述
    • 按基因類型分類的細分市場佔有率分析
    • 抗原
    • 細胞因子
    • 腫瘤抑制劑
    • 自殺
    • 不足
    • 生長因子
    • 受體
    • 其他

第 9 章：基因治療市場 - 按治療

  • 概述
    • 按療法分類的細分市場佔有率分析
    • 體內治療
    • 離體治療

第 10 章：基因治療市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 腫瘤疾病
    • 罕見疾病
    • 神經系統疾病
    • 其他疾病

第 11 章：基因治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美基因治療主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按向量類型）
    • 北美市場規模和預測（按基因類型）
    • 北美市場規模和預測（按治療）
    • 北美市場規模和預測（按應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲基因治療主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按向量類型）
    • 歐洲市場規模和預測（按基因類型）
    • 歐洲市場規模與預測（按治療）
    • 歐洲市場規模和預測（按應用）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區基因治療主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按向量類型）
    • 亞太地區市場規模和預測（按基因類型）
    • 亞太地區市場規模與預測（按治療）
    • 亞太地區市場規模與預測（按應用）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲基因治療主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按向量類型）
    • 拉丁美洲市場規模和預測（按基因類型）
    • 拉丁美洲市場規模與預測（按療法）
    • 拉丁美洲市場規模與預測（按應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲基因治療主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按向量類型）
    • 中東和非洲市場規模及預測（按基因類型）
    • 中東和非洲市場規模和預測（按療法）
    • 中東和非洲市場規模及預測（按應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 基因治療產業

  • 競爭儀表板
  • 公司簡介
    • REGENXBIO, Inc.
    • Oxford BioMedica plc
    • Dimension Therapeutics, Inc.
    • Bristol-Myers Squibb Company
    • SANOFI
    • Applied Genetic Technologies Corporation
    • F. Hoffmann-La Roche Ltd
    • Bluebird Bio, Inc.
    • Novartis AG
    • Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
    • UniQure NV
    • Shire Plc
    • Cellectis SA
    • Sangamo Therapeutics, Inc
    • Orchard Therapeutics
    • Gilead Lifesciences, Inc.
    • BENITEC BIOPHARMA
    • Sibiono GeneTech Co., Ltd
    • Shanghai Sunway Biotech Co., Ltd.
    • Gensight Biologics SA
    • Transgene
    • Calimmune, Inc.
    • Epeius Biotechnologies Corp.
    • Astellas Pharma Inc.
    • American Gene Technologies
    • BioMarin Pharmaceuticals, Inc.
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2021

REPORT HIGHLIGHT

Gene Therapy Market size was valued at USD 8,300 Million in 2022, expanding at a CAGR of 22.3% from 2023 to 2030.

Gene therapy is a technique that modifies a person's genes to treat or cure disease. Currently, gene therapies are being utilized to address specific conditions such as Leber congenital amaurosis, an eye disorder, and spinal muscular atrophy, a muscle disorder. However, extensive research is being conducted to ensure the safety and efficacy of numerous other gene therapies. Additionally, genome editing, a promising technique currently under investigation, holds the potential to treat various disorders in the near future. It is important to note that gene therapy products are regulated by the FDA's Center for Biologics Evaluation and Research (CBER) as they are considered biological products. Another innovative technique known as genome editing, exemplified by CRISPR-Cas9, takes a different approach by utilizing molecular tools to modify the existing DNA within cells, rather than introducing new genetic material.

Gene Therapy Market- Market Dynamics

Increase in the prevalence of chronic disorders such as cancer, rare disease genetic disorders, and others globally anticipated to drive the Gene Therapy market growth.

Gene therapy presents a promising strategy for combating cancer by specifically targeting the underlying genetic abnormalities responsible for its progression. According to the World Health Organization, there were approximately 18.1 million cancer cases worldwide in 2020, with 9.3 million affecting men and 8.8 million affecting women. While gene therapies primarily focus on addressing rare genetic disorders that lack effective traditional treatment options, the National Center for Biotechnology Information estimates that each year, 495,000 infants are born with congenital malformations, 390,000 with G6PD deficiency, 21,400 with Down syndrome, 9,000 with beta-thalassemia, 5,200 with sickle cell disease, and 9,760 with amino acid disorders. By tailoring treatment to an individual's specific genetic profile, gene therapy enables a more personalized approach to healthcare. Moreover, increased investment and funding in gene therapy research and development can create opportunities for market growth. However, the substantial cost associated with gene therapies presents challenges in terms of reimbursement and accessibility.

Gene Therapy Market- Key Insights

As per the analysis shared by our research analyst, the global Gene Therapy market is estimated to grow annually at a CAGR of around 22.3% over the forecast period (2023-2030)

Based on Vector Type segmentation, Non-viral vectors was predicted to show maximum market share in the year 2022

Based on Gene Type segmentation, Antigen was the leading type in 2022

Based on Therapy segmentation, In Vivo Therapy was the leading type in 2022

Based on Application segmentation, Oncological Disorders was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Gene Therapy Market- Segmentation Analysis:

The Global Gene Therapy Market is segmented based on Vector Type, Gene Type, Therapy, Application, and Region.

The market is divided into three categories based on Vector Type: Viral Vector and Non-Viral Vector. The market is primarily dominated by Non-Viral Vectors. Generally, Non-viral vectors exhibit a superior safety profile compared to viral vectors, thereby minimizing the chances of immune responses or unintended side effects. Moreover, Non-viral vectors possess the capability to accommodate larger DNA payloads, enabling the delivery of more extensive genetic material.

The market is divided into two categories based on Gene Type: Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth factors, Receptors and Others. The antigen segment dominates the market. Gene therapy plays a significant role in enhancing the immune system's ability to recognize and attack specific antigens associated with diseases.

The market is divided into three categories based on Therapy: In Vivo Therapy and Ex Vivo Therapy. In Vivo Therapy dominates the market. In Vivo Therapy holds a significant position in the market. Researchers are actively investigating in vivo gene therapy for various diseases, such as genetic disorders, specific forms of cancer, and other medical conditions. The aim is to modify the patient's genetic material to offer therapeutic advantages.

The market is divided into three categories based on Application: Oncological Disorders, Rare Diseases, Neurological Disorders and Other Diseases. The market is primarily dominated by the Oncological Disorders segment. Several gene therapies targeting oncological disorders are currently undergoing clinical trials at different stages. Certain therapies have obtained regulatory approvals for specific indications, whereas others are still in the investigational phases.

Gene Therapy Market- Geographical Insights

Geographically, this market is widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in the business. The North American region is expected to dominate the market's growth due to its highly advanced hospital infrastructure and the increasing demand for cell and gene therapy. North America boasts a robust healthcare ecosystem characterized by collaborations between academia, industry, and healthcare providers. This collaborative environment fosters innovation and expedites the translation of scientific discoveries into clinical applications. According to the American Hospital Association Information Technology, in 2018, 98.3% of hospitals had adopted Electronic Health Records (EHRs), with no differences based on Critical Access Hospital (CAH) status. Additionally, 58.7% and 55.6% of hospitals had adopted advanced Patient Engagement (PE) and Clinical Document Architecture (CDA) functions, respectively. The growing recognition of the potential of cell and gene therapies in treating various diseases, including cancer and genetic disorders, has led to an increasing demand for these therapies. The United States Food and Drug Administration (FDA) has approved four gene therapies for sale in the United States (U.S.) as of December 2022: Luxterna (voretigene neparvovec) approved in 2017, Zolgensma (onasemnogene abeparvovec-xioi) approved in 2019, Tecartus (brexucabtagene autoleucel) approved in 2020, and Hemgenix (etranacogene dezaparvovec) approved in 2022. Although still in its early stages, gene therapy holds the potential to treat and potentially cure diseases that were previously considered untreatable. Europe is projected to be the second-largest gene therapy market in the upcoming years, primarily due to the growing demand for personalized gene-based treatments.

Gene Therapy Market- Competitive Landscape:

The gene therapy market is experiencing significant growth with numerous therapies being developed for various indications. This presents a competitive landscape that requires thorough analysis to identify opportunities and challenges for gene therapy developers. In the pharmaceutical industry, the emergence of cell and gene therapy has brought about innovative treatments, with companies focusing on patents and investing strategically to introduce advanced technologies. These investments not only enhance patent portfolios but also position key players at the forefront of industry advancements. Recent deals highlight the importance of cell and gene therapy in the pharmaceutical sector, with dynamic shifts in strategic partnerships, patents, and job trends. The United States leads in global adoption, with collaborative efforts, transformative patents, and evolving job opportunities shaping the future of innovative advancements. As more gene therapies enter the market, companies must effectively prepare their products and go-to-market strategies to fulfill their promise of transforming patient lives. These companies must launch their products in a way that maximizes patient benefits while ensuring success in the market.

Recent Developments:

In Dec 22, 2021, Novartis announced that it entered into a definitive agreement to acquire all of the outstanding share capital of the UK-based ocular gene therapy company Gyroscope Therapeutics. Geographic atrophy is an advanced form of dry age-related macular degeneration leading to advanced and irreversible idea loss1.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENE THERAPY MARKET KEY PLAYERS

  • REGENXBIO, Inc.
  • Oxford BioMedica plc
  • Dimension Therapeutics, Inc.
  • Bristol-Myers Squibb Company
  • SANOFI
  • Applied Genetic Technologies Corporation
  • F. Hoffmann-La Roche Ltd
  • Bluebird Bio, Inc.
  • Novartis AG
  • Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
  • UniQure N.V.
  • Shire Plc
  • Cellectis S.A.
  • Sangamo Therapeutics, Inc
  • Orchard Therapeutics
  • Gilead Lifesciences, Inc.
  • BENITEC BIOPHARMA
  • Sibiono GeneTech Co., Ltd
  • Shanghai Sunway Biotech Co., Ltd.
  • Gensight Biologics S.A.
  • Transgene
  • Calimmune, Inc.
  • Epeius Biotechnologies Corp.
  • Astellas Pharma Inc.
  • American Gene Technologies
  • BioMarin Pharmaceuticals, Inc.
  • Others

GLOBAL GENE THERAPY MARKET, BY VECTOR TYPE

  • Viral Vector
  • Non-Viral Vector

GLOBAL GENE THERAPY MARKET, BY GENE TYPE

  • Antigen
  • Cytokine
  • Tumor Suppressor
  • Suicide
  • Deficiency
  • Growth factors
  • Receptors
  • Others

GLOBAL GENE THERAPY MARKET, BY THERAPY

  • In Vivo Therapy
  • Ex Vivo Therapy

GLOBAL GENE THERAPY MARKET, BY APPLICATION

  • Oncological Disorders
  • Rare Diseases
  • Neurological Disorders
  • Other Diseases

GLOBAL GENE THERAPY MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Gene Therapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Gene Therapy Market Snippet by Vector Type
    • 2.1.2. Gene Therapy Market Snippet by Gene Type
    • 2.1.3. Gene Therapy Market Snippet by Therapy
    • 2.1.4. Gene Therapy Market Snippet by Application
    • 2.1.5. Gene Therapy Market Snippet by Country
    • 2.1.6. Gene Therapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Gene Therapy Key Market Trends

  • 3.1. Gene Therapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Gene Therapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Gene Therapy Market Opportunities
  • 3.4. Gene Therapy Market Future Trends

4. Gene Therapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Gene Therapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Gene Therapy Market Landscape

  • 6.1. Gene Therapy Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Gene Therapy Market - By Vector Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Vector Type, 2022 & 2030 (%)
    • 7.1.2. Viral Vector
    • 7.1.3. Non-Viral Vector

8. Gene Therapy Market - By Gene Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Gene Type, 2022 & 2030 (%)
    • 8.1.2. Antigen
    • 8.1.3. Cytokine
    • 8.1.4. Tumor Suppressor
    • 8.1.5. Suicide
    • 8.1.6. Deficiency
    • 8.1.7. Growth factors
    • 8.1.8. Receptors
    • 8.1.9. Others

9. Gene Therapy Market - By Therapy

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Therapy, 2022 & 2030 (%)
    • 9.1.2. In Vivo Therapy
    • 9.1.3. Ex Vivo Therapy

10. Gene Therapy Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 10.1.2. Oncological Disorders
    • 10.1.3. Rare Diseases
    • 10.1.4. Neurological Disorders
    • 10.1.5. Other Diseases

11. Gene Therapy Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Gene Therapy Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Gene Therapy Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Gene Therapy Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Gene Therapy Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Gene Therapy Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Gene Therapy Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. REGENXBIO, Inc.
    • 12.2.2. Oxford BioMedica plc
    • 12.2.3. Dimension Therapeutics, Inc.
    • 12.2.4. Bristol-Myers Squibb Company
    • 12.2.5. SANOFI
    • 12.2.6. Applied Genetic Technologies Corporation
    • 12.2.7. F. Hoffmann-La Roche Ltd
    • 12.2.8. Bluebird Bio, Inc.
    • 12.2.9. Novartis AG
    • 12.2.10. Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
    • 12.2.11. UniQure N.V.
    • 12.2.12. Shire Plc
    • 12.2.13. Cellectis S.A.
    • 12.2.14. Sangamo Therapeutics, Inc
    • 12.2.15. Orchard Therapeutics
    • 12.2.16. Gilead Lifesciences, Inc.
    • 12.2.17. BENITEC BIOPHARMA
    • 12.2.18. Sibiono GeneTech Co., Ltd
    • 12.2.19. Shanghai Sunway Biotech Co., Ltd.
    • 12.2.20. Gensight Biologics S.A.
    • 12.2.21. Transgene
    • 12.2.22. Calimmune, Inc.
    • 12.2.23. Epeius Biotechnologies Corp.
    • 12.2.24. Astellas Pharma Inc.
    • 12.2.25. American Gene Technologies
    • 12.2.26. BioMarin Pharmaceuticals, Inc.
    • 12.2.27. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Gene Therapy Market: Vector Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Vector Type
  • TABLE Global Gene Therapy Market, by Vector Type 2018-2030 (USD Million)
  • TABLE Gene Therapy Market: Gene Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Gene Type
  • TABLE Global Gene Therapy Market, by Gene Type 2018-2030 (USD Million)
  • TABLE Gene Therapy Market: Therapy Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapy
  • TABLE Global Gene Therapy Market, by Therapy 2018-2030 (USD Million)
  • TABLE Gene Therapy Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Gene Therapy Market, by Application 2018-2030 (USD Million)
  • TABLE Gene Therapy Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Gene Therapy Market, by Region 2018-2030 (USD Million)
  • TABLE North America Gene Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
  • TABLE North America Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
  • TABLE North America Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE North America Gene Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Gene Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
  • TABLE Europe Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
  • TABLE Europe Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Europe Gene Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Gene Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Asia Pacific Gene Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Gene Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
  • TABLE Latin America Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
  • TABLE Latin America Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Latin America Gene Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Gene Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Gene Therapy Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Gene Therapy Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Vector Type segment market share analysis, 2022 & 2030
  • FIGURE Vector Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Gene Type segment market share analysis, 2022 & 2030
  • FIGURE Gene Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Therapy segment market share analysis, 2022 & 2030
  • FIGURE Therapy segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Gene Therapy Market share and leading players, 2022
  • FIGURE Europe Gene Therapy Market share and leading players, 2022
  • FIGURE Asia Pacific Gene Therapy Market share and leading players, 2022
  • FIGURE Latin America Gene Therapy Market share and leading players, 2022
  • FIGURE Middle East and Africa Gene Therapy Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Gene Therapy Market share analysis by country, 2022
  • FIGURE Germany Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Gene Therapy Market share analysis by country, 2022
  • FIGURE India Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Gene Therapy Market share analysis by country, 2022
  • FIGURE Brazil Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Gene Therapy Market share analysis by country, 2022
  • FIGURE Saudi Arabia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)